Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

Detalles Bibliográficos
Autores principales: Sasaki, Yasutsuna, Hamada, Kazuyuki, Kaneta, Toshikado, Takahashi, Takehiro, Kubota, Yutaro, Ishida, Hiroo, Ichikawa, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556401/
https://www.ncbi.nlm.nih.gov/pubmed/26268893
http://dx.doi.org/10.1111/cas.12708
_version_ 1782388344690311168
author Sasaki, Yasutsuna
Hamada, Kazuyuki
Kaneta, Toshikado
Takahashi, Takehiro
Kubota, Yutaro
Ishida, Hiroo
Ichikawa, Wataru
author_facet Sasaki, Yasutsuna
Hamada, Kazuyuki
Kaneta, Toshikado
Takahashi, Takehiro
Kubota, Yutaro
Ishida, Hiroo
Ichikawa, Wataru
author_sort Sasaki, Yasutsuna
collection PubMed
description
format Online
Article
Text
id pubmed-4556401
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45564012015-10-05 Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer? Sasaki, Yasutsuna Hamada, Kazuyuki Kaneta, Toshikado Takahashi, Takehiro Kubota, Yutaro Ishida, Hiroo Ichikawa, Wataru Cancer Sci Letters to the Editor John Wiley & Sons, Ltd 2015-08 2015-08-12 /pmc/articles/PMC4556401/ /pubmed/26268893 http://dx.doi.org/10.1111/cas.12708 Text en © 2015 The Authors. Cancer Science published by Wiley Publishing Asia Pty Ltd on behalf of Japanese Cancer Association. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Sasaki, Yasutsuna
Hamada, Kazuyuki
Kaneta, Toshikado
Takahashi, Takehiro
Kubota, Yutaro
Ishida, Hiroo
Ichikawa, Wataru
Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
title Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
title_full Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
title_fullStr Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
title_full_unstemmed Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
title_short Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?
title_sort is repeating folfirinox in the original dosage and treatment schedule tolerable in japanese patients with pancreatic cancer?
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556401/
https://www.ncbi.nlm.nih.gov/pubmed/26268893
http://dx.doi.org/10.1111/cas.12708
work_keys_str_mv AT sasakiyasutsuna isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer
AT hamadakazuyuki isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer
AT kanetatoshikado isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer
AT takahashitakehiro isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer
AT kubotayutaro isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer
AT ishidahiroo isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer
AT ichikawawataru isrepeatingfolfirinoxintheoriginaldosageandtreatmentscheduletolerableinjapanesepatientswithpancreaticcancer

Ejemplares similares